Skip to content

Legal status · Australia

Is Orforglipron legal in Australia?

Written by Reviewed Sep 2026

Not approvedMetabolicStudies in people cited: 11

Direct answer

No. Orforglipron is not approved for any medical use in Australia. Its legal category is "Not yet registered". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 8 completed human trials are cited on its profile.

People given it
17,383
Found nothing
0

Legal category

Not yet registered

TGA registration and the Poisons Standard schedule, from the Orforglipron profile.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Orforglipron in Australia at a glance

Legal categoryNot yet registered
TGA approval statusNot approved by TGA; investigational (still being tested in trials)
Studies in people11 of 11 sources on the profile
ReviewedSep 2026

The legal category and note come from the Orforglipron profile. We checked them against Therapeutic Goods Administration (TGA) listings on the reviewed date.

What this means

  • 01

    Orforglipron is being tested in registered clinical trials (official studies in people). TGA has not approved it for sale in Australia.

  • 02

    The only legal ways for a person to get it are to join a trial, or to use an official early-access program where one exists. There is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial supplies. That label does not make them legal to use in people.

What Orforglipron is

A once-a-day GLP-1 pill instead of a shot. It is a small molecule, not a peptide. The FDA approved it on April 1, 2026 as Foundayo for weight loss.

Orforglipron is a GLP-1 drug you swallow as a pill. It is a small molecule, not an injected peptide, which could make these drugs easier to make in bulk.

How it works: It switches on the GLP-1 receptor, like the shots do, but it works as a pill. That cuts appetite and helps the body release insulin when blood sugar is high.

Approval history: FDA-approved April 1, 2026 as Foundayo for long-term weight management. It carries a boxed warning, the FDA's strongest, about thyroid C-cell tumors

How TGA treats this kind of product

Registers or lists medicines and health products on the ARTG, its official register. It also sorts substances into schedules in the Poisons Standard. Many peptides are Schedule 4 (prescription only). So having them without a prescription, or importing them for yourself, is restricted. That is true even when no product is registered.

The legal category above is how The Longevity Archive reads Therapeutic Goods Administration listings for Orforglipron on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check TGA directly

Orforglipron in sport and the military

Whether Orforglipron is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in Australia. Before you compete or get tested, look up Orforglipron by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Orforglipron in other countries

Frequently asked questions

Is Orforglipron legal in Australia?

No. Orforglipron is not approved for any medical use in Australia. Its legal category is "Not yet registered". The only legal way to get it is to join a registered clinical trial (an official study in people). A "research use only" label on vials sold online does not make them legal to use in people. On the evidence, 8 completed human trials are cited on its profile.

Can I buy Orforglipron in Australia?

There is no approved product to buy. In Australia, Orforglipron has the legal category "Not yet registered". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.

Is Orforglipron TGA approved?

No. In Australia, Orforglipron has the legal category "Not yet registered". That is not a TGA approval to sell it. For comparison, its US FDA status is: FDA-approved April 1, 2026 as Foundayo for long-term weight management. It carries a boxed warning, the FDA's strongest, about thyroid C-cell tumors. On the evidence, 8 completed human trials are cited on its profile.

Related compounds in Australia

Full research profile

How Orforglipron works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Orforglipron profile

This page is general information about the legal status of Orforglipron in Australia, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Therapeutic Goods Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.